FIJYX Mutual Fund

FIJYX Mutual Fund

NAV$53.23

Fund Essentials - as of Jan 31, 2026

Net Assets
$184M
Expense Ratio
0.58%
Dividend Yield (Current)
0.99%
Holdings
92
Inception Date
Oct 2, 2018
Fund Family
Fidelity Investments (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+22.61%
1 Year+77.69%
3 Year+26.42%
5 Year+12.81%

Asset Allocation

Stocks: 95.76%
Bonds: 0.05%
Cash: 3.77%
Other: 0.42%

Top Holdings

View All →
TickerNameWeight
ABBVAbbvie Inc Health Care16.61%
GILDGilead Sciences Inc6.57%
ALNYAlnylam Pharmac..5.02%
ASNDAscendis Pharma A/S4.49%
COGTCogent Biosciences Inc3.83%
Top 10 Concentration: 53.22%Report Date: Jan 31, 2026
Download all 92 holdings for FIJYX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.99%
Frequency
Annually
Latest Distribution
$5.44
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
FundXLS Pro
See how FIJYX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
X-ray my whole portfolio$45/quarter Pro · Cancel anytime
From MarketXLS, trusted since 2014.

FIJYX Mutual Fund Overview

FIJYX Mutual Fund (Fidelity Advisor Biotechnology Fund Class Z) is managed by Fidelity Investments (US) with $184.2M in net assets. FIJYX expense ratio is 0.58%, holding 92 positions across sectors including Health Care, Financials. Inception date: 2018-10-02.

FIJYX performance shows a YTD return of 22.61%. The 1-year return is 77.69% and the 5-year return is 12.81%. FIJYX dividend yield stands at 0.99%, paid annually.

FIJYX top holdings include Abbvie Inc Health Care (16.6%), Gilead Sciences Inc (6.6%), Alnylam Pharmac.. (5.0%), Ascendis Pharma A/S (4.5%), Cogent Biosciences Inc (3.8%). Go to all FIJYX holdings, FIJYX sectors, or FIJYX dividends.

FIJYX can be compared against other funds. Use FIJYX overlap to find shared positions, or FIJYX vs another fund for a side-by-side view. FIJYX alternatives are available via the screener, along with tax-loss harvesting opportunities.